Mayers Irvin, Hurst Thomas, Radomski Anna, Johnson David, Fricker Simon, Bridger Gary, Cameron Beth, Darkes Marilyn, Radomski Marek W
Department of Medicine, University of Alberta, Edmonton, Canada.
J Thorac Cardiovasc Surg. 2003 Mar;125(3):661-8. doi: 10.1067/mtc.2003.38.
We tested whether nitric oxide scavenging with a ruthenium-based compound (AMD6221) would improve hemodynamics and alter nitric oxide synthase and matrix metalloproteinase activities in a canine model of cardiopulmonary bypass.
Dogs were randomized to either cardiopulmonary bypass (n = 12) or control (n = 12) groups. They were further randomized to receive a continuous infusion of AMD6221 or placebo. Cardiopulmonary bypass was maintained for 90 minutes, and then, 4 hours later, dogs were killed. Cardiac, lung, and brain sections were snap frozen in liquid nitrogen for determination of nitric oxide synthase, matrix metalloproteinase 2, and matrix metalloproteinase 9 activities.
After cardiopulmonary bypass, 3 of 6 placebo-treated (cardiopulmonary bypass-placebo) and 0 of 6 AMD6221-treated (cardiopulmonary bypass-6221) animals required phenylephrine infusion to maintain a predetermined blood pressure (P <.05). Total fluid administration was lower in the cardiopulmonary bypass-6221 group compared with that in the cardiopulmonary bypass-placebo group (983 +/- 134 vs 1617 +/- 254 mL, respectively; P <.005). After cardiopulmonary bypass, matrix metalloproteinase 2 and matrix metalloproteinase 9 activities in the lung, left ventricle, and left atrium were decreased in the cardiopulmonary bypass-6221 group compared with that in the cardiopulmonary bypass-placebo group (P <.05). Ca(2+)-independent nitric oxide synthase activity and matrix metalloproteinase 2 activity in the brain were also lower (P <.05) in the cardiopulmonary bypass-SCV group. Finally, neutrophil expression of CD18, an adhesion complex, was lower at 4 hours after cardiopulmonary bypass in the cardiopulmonary bypass-6221 group compared with that in the cardiopulmonary bypass-placebo group (38 +/- 27 vs 81 +/- 11; P <.05).
We found that (1) infusion of an nitric oxide scavenger, AMD6221, was associated with improved predefined hemodynamics; (2) cardiopulmonary bypass increased activities of Ca(2+)-independent nitric oxide synthase and matrix metalloproteinases in multiple organs; and (3) AMD6221 could ameliorate the increased generation of nitric oxide and increased matrix metalloproteinase activities.
我们测试了使用一种钌基化合物(AMD6221)清除一氧化氮是否会改善血流动力学,并改变体外循环犬模型中一氧化氮合酶和基质金属蛋白酶的活性。
将犬随机分为体外循环组(n = 12)和对照组(n = 12)。再将它们进一步随机分为接受AMD6221持续输注或安慰剂的组。体外循环维持90分钟,然后在4小时后处死犬。将心脏、肺和脑切片在液氮中速冻,以测定一氧化氮合酶、基质金属蛋白酶2和基质金属蛋白酶9的活性。
体外循环后,6只接受安慰剂治疗的动物(体外循环-安慰剂组)中有3只,而6只接受AMD6221治疗的动物(体外循环-6221组)中无一只需要输注去氧肾上腺素来维持预定血压(P <.05)。与体外循环-安慰剂组相比,体外循环-6221组的总液体输注量更低(分别为983±134 vs 1617±254 mL;P <.005)。体外循环后,与体外循环-安慰剂组相比,体外循环-6221组肺、左心室和左心房中的基质金属蛋白酶2和基质金属蛋白酶9活性降低(P <.05)。体外循环-SCV组脑中的钙非依赖性一氧化氮合酶活性和基质金属蛋白酶2活性也较低(P <.05)。最后,与体外循环-安慰剂组相比,体外循环-6221组在体外循环后4小时中性粒细胞CD18(一种黏附复合物)的表达更低(38±27 vs 81±11;P <.05)。
我们发现:(1)输注一氧化氮清除剂AMD6221与改善预定的血流动力学有关;(2)体外循环增加了多个器官中钙非依赖性一氧化氮合酶和基质金属蛋白酶的活性;(3)AMD6221可以改善一氧化氮生成增加和基质金属蛋白酶活性增加的情况。